CD38 and B-cell chronic lymphocytic leukemia: Outside of CLL, studies in mantle-cell lymphoma,41 diffuse large B cell lymphoma,42 and B cell acute lymphoblastic leukemia43 correlated CD38 expression to adverse survival rates, while CD38 is constitutively expressed on multiple myeloma cells.44